Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	34.10	92.63	69.07
Graham Fair Price	5.53	26.01	24.65
PEG	-2.01	5.02	-5.12
Price/Book	-0.10	4.55	4.55
Price/Cash Flow	115.61	185.29	85.94
Prices/Earnings	-5.99	42.31	45.01
Price/Sales	-2.42	20.47	20.98
Price/FCF	115.61	185.29	85.94
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.72	0.34	0.33
Operating Margin	-32.77	0.18	0.26
ROA	11.27	0.02	0.02
ROE	0.03	0.03	6.27
ROIC	0.04	0.02	-31.65
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.13	79.72
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.37	-0.30	-20.28
EPS QOQ	-0.09	0.08	-4.07
FCF QOQ	0.46	-0.53	13.54
Revenue QOQ	< 0.005	0.05	782.29
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	64.13	62.82	-2.04
Days Sales Outstanding (DSO)	49.30	52.53	6.55
Inventory Turnover	1.40	1.43	2.09
Debt/Capitalization	0.23	0.22	-3.77
Quick Ratio	1.28	1.61	25.95
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	32.68	33.45	2.37
Cash	2.00	1.87	-6.35
Capex	-0.36	-0.21	40.30
Free Cash Flow	1.73	0.82	-52.57
Revenue	7.09	7.43	4.80
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.12	2.61	23.37
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.63	4.68	29.07
Naive Interpretation	Member

06 - Financial Health · Bad

Rating